Showing results (141-150 of 292) with videos related to
Sort By:
Pageof 30
Scandinavian Journal of Rheumatology|January 1, 1995
Mental health status in systemic lupus erythematosusR Omdal, G Husby, S I MellgrenThe Biochemical Journal|October 15, 1994
Characterization of proteoglycans associated with mouse splenic AA amyloidosisT Stenstad, J H Magnus, G HusbyTherapeutic Drug Monitoring|November 1, 1991
Naproxen free plasma concentrations and unbound fractions in patients with osteoarthritis: relation to age, sex, efficacy, and adverse eventsO Hundal, H E Rugstad, G HusbyBiological Chemistry Hoppe-Seyler|July 1, 1985
The amino-acid sequence of the variable region of a carbohydrate-containing amyloid fibril protein EPS (immunoglobulin light chain, type lambda)K G Toft, K Sletten, G HusbyClinical and Experimental Immunology|June 1, 1983
Comparative studies of the high molecular weight amyloid fibril proteins and similar components from normal tissuesD L Scott, G Marhaug, G HusbyThe Journal of Biological Chemistry|June 15, 1990
Mink serum amyloid A protein. Expression and primary structure based on cDNA sequencesG Marhaug, G Husby, S B DowtonScandinavian Journal of Rheumatology|July 18, 2000
No permanent reduction in bone mineral density during treatment of polymyalgia rheumatica and temporal arteritis using low dose corticosteroidsG Haugeberg, G Myklebust, H Dovland, et al.Lupus|September 12, 2014
Mortality and years of potential life loss in systemic lupus erythematosus: a population-based cohort studyK Lerang, I-M Gilboe, D Steinar Thelle, et al.Scandinavian Journal of Rheumatology|August 13, 2005
A longitudinal study of calprotectin in patients with polymyalgia rheumatica or temporal arteritis: relation to disease activityJ G Brun, T M Madland, J T Gran, et al.The Journal of Rheumatology|March 15, 2001
Disease course in systemic lupus erythematosus: changes in health status, disease activity, and organ damage after 2 yearsI M Gilboe, T K Kvien, G HusbyPageof 30